Attila Kofalvi
Coimbra, 3004504, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Astrocytic GPR55 receptors promote glycolysis.
Journal: Journal of cannabis research
Published: August 11, 2025
Cannabis, Endocannabinoids and Brain Development: From Embryogenesis to Adolescence.
Journal: Cells
Published: October 17, 2024
Comparing adenosine A2A receptor modulation of cannabinoid CB1 receptor-mediated inhibition of GABA and glutamate release in rodent striatal nerve terminals.
Journal: The European journal of neuroscience
Published: July 10, 2024
A combination of Δ9-tetrahydrocannabinol and cannabidiol modulates glutamate dynamics in the hippocampus of an animal model of Alzheimer's disease.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: April 25, 2024
Targeting corticostriatal transmission for the treatment of cannabinoid use disorder.
Journal: Trends in pharmacological sciences
Published: April 19, 2023
Brain Iron Deficiency Changes the Stoichiometry of Adenosine Receptor Subtypes in Cortico-Striatal Terminals: Implications for Restless Legs Syndrome.
Journal: Molecules (Basel, Switzerland)
Published: January 31, 2022
Diabetes and Cannabinoid CB1 receptor deficiency promote similar early onset aging-like changes in the skin.
Journal: Experimental gerontology
Published: May 23, 2021
An optimized spectrophotometric assay reveals increased activity of enzymes involved in 2-arachidonoyl glycerol turnover in the cerebral cortex of a rat model of Alzheimer's disease.
Journal: The European journal of neuroscience
Published: June 03, 2020
Transient gain of function of cannabinoid CB1 receptors in the control of frontocortical glucose consumption in a rat model of Type-1 diabetes.
Journal: Brain research bulletin
Published: March 04, 2020
Control of glutamate release by complexes of adenosine and cannabinoid receptors.
Journal: BMC biology
Published: October 10, 2019
Memory deficits induced by chronic cannabinoid exposure are prevented by adenosine A2AR receptor antagonism.
Journal: Neuropharmacology
Published: December 18, 2018
Chronic insulinopenia/hyperglycemia decreases cannabinoid CB1 receptor density and impairs glucose uptake in the mouse forebrain.
Journal: Brain research bulletin
Published: October 21, 2018
Last Updated: 09/26/2026